From Wikipedia, the free encyclopedia
|Source||Humanized (from mouse)|
|Mol. mass||143.1 kDa|
|(what is this?)|
Enavatuzumab is a humanized monoclonal antibody used in the treatment of solid tumors.
Enavatuzumab was developed by Facet Biotech Corp.
- "Statement On A Nonproprietary Name Adopted By The USAN Council: Enavatuzumab". American Medical Association.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|